Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05827094 · ClinicalTrials.gov registry record · NA

Pilot Mobile for Dementia and Frailty

A NA study of Dementia and Frailty, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
19
Enrollment target
1
Study location

NCT05827094: Completed NA study of Dementia and Frailty, sponsored by University of Washington.

NCT05827094 is a NA study of Dementia and Frailty that has completed, run by University of Washington. The registered enrollment target is 19 participants, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05827094, a NA study of Dementia and Frailty, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

In this project, we propose to build on our Stage I formative work (according to the NIH Stage Model for Behavioral Intervention Development), where we developed fully functional prototypes of a mobile intervention aimed at improving adherence to Mediterranean Diet (MedD) for older adults with frailty and early dementia to complete the Stage II exploratory work, where the intervention will undergo further feasibility, acceptability, and preliminary efficacy tests. The intervention includes a patient-facing app that allows users to track their diet and receive personalized feedback concerning opportunities for improvement and recipes for breakfast, lunch, dinner, and snacks, informational materials about MedD, and a chat feature. On the other end, a web-based provider interface allows clinicians to review patient progress, suggest meal plans, and send and receive messages. The pilot randomized controlled trial, conducted over three months, will compare usual care to usual care plus mobile intervention to gather preliminary efficacy data concerning a change in adherence to MedD score (primary outcome). Mechanistic and secondary outcomes will include MedD knowledge, constructs from Social Cognitive Theory (self-efficacy, outcome expectation, self-regulation, and social support), platform use, anthropometric, and functional measures. Feasibility will be evaluated in terms of recruitment and retention outcomes. Acceptability will be determined through post-intervention semi-structured interviews and structured survey measures.

Primary Outcome

Mediterranean Diet adherence was measured using an Food Frequency Questionnaire (FFQ) adherence to Mediterranean Diet (aMED) score. The self-administered FFQ asks participants to report the frequency of consumption and portion size of approximately 125-line items over the last 3 months. A series of foods or beverages define each line item. The aMED score was designed to assess adherence to a Mediterranean dietary pattern. aMED scores range from 0 (nonadherence) to 9 (perfect adherence)

Conditions Studied

Interventions

  • OTHER Usual Care
  • OTHER Mobile app

Study Locations (1)

Washington

  • Univeristy of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2023-06-06
Est. Completion 2024-03-15
Phase NA
University of Washington

1,048 total trials

What the finished NCT05827094 record still lists

NCT05827094 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT05827094 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT05827094 about?

NCT05827094 is a clinical study titled "Pilot Mobile for Dementia and Frailty". In this project, we propose to build on our Stage I formative work (according to the NIH Stage Model for Behavioral Intervention Development), where we developed fully functional prototypes of a mobile intervention aimed at improving adherence to Mediterranean Diet (MedD) for older adults with frail...

What is the current status of trial NCT05827094?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2023-06-06. Estimated completion is 2024-03-15.

What conditions does trial NCT05827094 study?

This clinical trial studies the following conditions: Dementia, Frailty.

What interventions are being tested in trial NCT05827094?

The interventions under investigation include: Usual Care (OTHER), Mobile app (OTHER).

Who is sponsoring clinical trial NCT05827094?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05827094 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05827094's enrollment target sits among peer trials

19 189th of 199 higher than 11 of 199 other Dementia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05827094, the US trial registry maintained by the National Library of Medicine. NCT05827094 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.